Last reviewed · How we verify

NCT03925363

A Mobile Application to Increase Physical Activity

Status unknown NA Last updated 2 July 2019
What this trial tests

NA trial testing Physical activity mobile-application in Physical Activity in 4,000 participants. Status unknown.

Timeline
25 August 2019
Primary endpoint
1 January 2021
1 January 2023

Quick facts

Lead sponsorRegion Västerbotten
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment4,000
Start date25 August 2019
Primary completion1 January 2021
Estimated completion1 January 2023

Drugs / interventions tested

Conditions studied

Sponsor

Region Västerbotten — full company profile →

Who can join

Adults 70 to 75, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A mobile application will be tested in elderly men and women that is randomized to an application (blind-app) that registers physical activity or an application (feedback-app) where participants in addition set goals for physical activity and gets feedback from the application when these goals are achieved. Participants are randomized in permuted blocks of 10 to the blind-app or feedback-app. The primary outcome is increased physical activity. Secondary outcomes include, cardiovascular disease, diabetes, death, dementia, cancer, falls and fractures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Region Västerbotten trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03925363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing